Clinical Trial Update: A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating budesonide/formoterol fumarate metered-dose inhaler in adults and adolescents with inadequately controlled asthma has completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2026-01-28